 |
Bethanidine sulfate |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of recurrence of primary ventricular fibrillation |
| USA Market Approval | USA |
| USA Designation Date | 1989-11-24 00:00:00 |
| Sponsor | Medco Research, Inc.;8455 Beverly Blvd., Suite 308;Los Angeles, California, 90048 |
